Insider · CIK 0001770681
Chen Franco-Yehuda
Files at DRIO (DarioHealth Corp.). First filing -, latest -.
Chen Franco-Yehuda files SEC Form 4 as CFO at DRIO (DarioHealth Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Chen Franco-Yehuda has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +95,000 | $0.00 | $0 | 125,000 | 15 d ago |
| Sep 11, 2025 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 30,000 | Sep 15, 2025 |
| May 15, 2025 | DRIO DarioHealth Corp. | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 500,000 | May 15, 2025 |
Questions about Chen Franco-Yehuda
Answered from the filings on this page, as of the latest one.
Is Chen Franco-Yehuda buying or selling?
Chen Franco-Yehuda has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Chen Franco-Yehuda's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chen Franco-Yehuda has 0.
Where does Chen Franco-Yehuda file Form 4?
Chen Franco-Yehuda has filed Form 4 at DRIO (DarioHealth Corp.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.